October 23, 2019
FDA approves Trikafta to treat cystic fibrosis in patients older than 12
Vertex Pharmaceuticals got approval from the USFDA for Trikafta, for treating cystic fibrosis in patients older than 12
Pharmaceuticals, Biotechnology and Life Sciences
Vertex Pharmaceuticals got approval from the USFDA for Trikafta, for treating cystic fibrosis in patients older than 12
Vertex Pharmaceuticals received FDA’s approval for Trikafta (elexacaftor/tezacaftor/ivacaftor), for treating cystic fibrosis in patients older than 12, who have at…